Yale Therapeutic Radiology
Smilow Cancer Hospital at Yale New Haven
35 Park Street, Fl Ste Lower Level
New Haven, CT 06511
- Yale Therapeutic RadiologySmilow Cancer Hospital at Yale New Haven35 Park Street, Fl Ste Lower LevelNew Haven, CT 06511
Thomas Hayman, MD, PhD
Head & Neck Radiotherapy, Thoracic Radiotherapy, Prostate & Genitourinary Radiotherapy
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From patients or physicians
Board Certified in
Radiation Oncology
Biography
Thomas Hayman, MD, PhD, is a therapeutic radiologist who specializes in treating cancers of the lung, head and neck, skin, and more. He employs advanced radiation techniques, including stereotactic radiosurgery and intensity-modulated radiation therapy (which uses precise computer planning to target tumors), to manage various malignancies such as those in the central nervous system, prostate, and gastrointestinal tract.
As an assistant professor of therapeutic radiology at Yale School of Medicine, Dr. Hayman studies how cancer cells resist damage from radiation. He aims to discover better ways to overcome these defenses, ultimately translating new findings into clinical practice.
Dr. Hayman received his medical degree and doctoral degree from the University of South Florida Morsani College of Medicine. He completed a residency in radiation oncology at Yale New Haven Hospital.
Titles
- Assistant Professor of Therapeutic Radiology
Education & Training
- MDUSF Health Morsani College of Medicine (2015)
- PhDUSF Health Morsani College of Medicine (2013)
Additional Information
Board Certifications
- AB of Radiology, Radiation Oncology (2021)
Publications
- Ninia JG, Verma N, Long JB, Laird JH, Hicks DF, Hayman TJ, Knowlton CA, Campbell AM, Housri N, Peters GW, Al Feghali KA, de Jong D, Chiang AC, Park HS. Consolidative Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Outcomes Based on Completeness of Consolidation and Oligometastatic State. Clinical Lung Cancer 2026, 27 DOI: 10.1016/j.cllc.2026.03.009.
- MacNeil T, Hayman T, Li S, Moutafi M, Martinez-Morilla S, Vathiotis I, Hu R, Harari P, Burtness B, Liu H, Kimple R, Rimm D, Contessa J. STING predicts patterns of failure in locally advanced head and neck squamous cell carcinoma. JNCI Cancer Spectrum 2026, 10: pkaf126. PMID: 41569294, PMCID: PMC12972654, DOI: 10.1093/jncics/pkaf126.
- Ziaks T, Park H, Oh P, Hicks D, Knowlton C, Laird J, Hayman T. P3.13.26 Sequencing of Stereotactic Body Radiation Therapy and Chemotherapy in Stage I Small Cell Lung Cancer: Practice Patterns and Outcomes. Journal Of Thoracic Oncology 2025, 20: s516. DOI: 10.1016/j.jtho.2025.09.962.
- Lee V, Oh P, Jani K, Rybkin A, Kim S, Patel A, Kang J, Park H, Hayman T. P1.07.36 A Three-Gene Signature Predicting Local Recurrence in Stage I-III NSCLC Patients Treated With Radiation Therapy. Journal Of Thoracic Oncology 2025, 20: s151. DOI: 10.1016/j.jtho.2025.09.279.
- Shen J, Oh P, Hayman T, Knowlton C, Hicks D, Laird J, Park H. Cardiac Toxicity Following SBRT for Centrally Located Lung Tumors: Assessing the Impact of Radiation Dose Metrics. International Journal Of Radiation Oncology • Biology • Physics 2025, 123: e212. DOI: 10.1016/j.ijrobp.2025.06.3759.
- Lawlor M, Park H, Knowlton C, Housri N, Hicks D, Laird J, Evans S, Hayman T. Retrospective Study of the Efficacy and Safety of Lung Malignancy Radiation In-Field of Prior Ipsilateral Breast Radiation. International Journal Of Radiation Oncology • Biology • Physics 2025, 123: e179-e180. DOI: 10.1016/j.ijrobp.2025.06.3687.
- Lee V, Rybkin A, Oh P, Izreig S, Park H, Morris L, Hayman T, Young M, Pickering C, Mehra S, Lee N, Kang J. The Role of TP53 in Nodal Metastasis: A Molecular Guide for Neck Management in Oral Cavity Cancer. International Journal Of Radiation Oncology • Biology • Physics 2025, 123: s196. DOI: 10.1016/j.ijrobp.2025.07.1284.
- Lee V, Oh P, Rybkin A, Jani K, Patel A, Hayman T, Kim S, Park H. Genomic Predictors of Brain Metastases in Non-Small Cell Lung Cancer: Implications for Early Detection and Targeted Surveillance. International Journal Of Radiation Oncology • Biology • Physics 2025, 123: e180-e181. DOI: 10.1016/j.ijrobp.2025.06.3689.
- Banik K, Hayman T. Role of PLK4 inhibition in cancer therapy. Cancer And Metastasis Reviews 2025, 44: 55. PMID: 40512236, DOI: 10.1007/s10555-025-10271-5.
- Dominguez-Vigil I, Banik K, Baro M, Contessa J, Hayman T. PLK4 Inhibition as a Strategy to Enhance Non-Small Cell Lung Cancer Radiosensitivity. Molecular Cancer Therapeutics 2025, 24: 1350-1361. PMID: 40296663, PMCID: PMC12353405, DOI: 10.1158/1535-7163.mct-24-0978.
- Ninia J, Verma N, Laird J, Hayman T, Knowlton C, Peters G, Campbell A, Housri N, Feghali K, de Jong D, Park H. Complete vs. Incomplete Consolidative Radiotherapy in Patients with Extensive-Stage Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2024, 120: e51. DOI: 10.1016/j.ijrobp.2024.07.1890.
- Hayman T. Rethinking the use of germline CHEK2 mutation as a marker for PARP inhibitor sensitivity. JNCI Cancer Spectrum 2024, 8: pkae045. PMID: 38950525, PMCID: PMC11216723, DOI: 10.1093/jncics/pkae045.
- Verma N, Laird J, Moore N, Hayman T, Housri N, Peters G, Knowlton C, Jairam V, Campbell A, Park H. Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy. Advances In Radiation Oncology 2024, 9: 101500. PMID: 38699671, PMCID: PMC11063223, DOI: 10.1016/j.adro.2024.101500.
- Sasse A, Oh P, Saeed N, Yang D, Hayman T, Knowlton C, Peters G, Campbell A, Laird J, Housri N, Park H. Dose-volume Predictors of Radiation Pneumonitis Following Thoracic Hypofractionated Radiotherapy. International Journal Of Radiation Oncology • Biology • Physics 2024, 118: e5. DOI: 10.1016/j.ijrobp.2023.10.054.
- Dosimetric Factors Associated with Esophagitis Following Hypofractionated Radiotherapy to the ThoraxSasse, Oh P, Saeed N, Yang D, Peters G, Hayman T, Housri N, Laird J, Campbell A, Knowlton C, Park H. Dosimetric Factors Associated with Esophagitis Following Hypofractionated Radiotherapy to the Thorax. International Journal Of Radiation Oncology • Biology • Physics 2024, 118: e7-e8. DOI: 10.1016/j.ijrobp.2023.10.059.
- Bennett C, Jackson V, Pettikiriarachchi A, Hayman T, Schaeper U, Moir-Meyer G, Fielding K, Ataide R, Clucas D, Baldi A, Garnham A, Li-Wai-Suen C, Loughran S, Baxter E, Green A, Alexander W, Bahlo M, Burbury K, Ng A, Pasricha S. Iron homeostasis governs erythroid phenotype in polycythemia vera. Blood 2023, 141: 3199-3214. PMID: 36928379, PMCID: PMC10646816, DOI: 10.1182/blood.2022016779.
- Hayman T, Hickey P, Amann-Zalcenstein D, Bennett C, Ataide R, Sthity R, Khandaker A, Islam K, Stracke K, Yassi N, Watson R, Long J, Westcott J, Krebs N, King J, Black R, Islam M, McDonald C, Pasricha S. Zinc Supplementation with or without Additional Micronutrients Does Not Affect Peripheral Blood Gene Expression or Serum Cytokine Level in Bangladeshi Children. Nutrients 2021, 13: 3516. PMID: 34684517, PMCID: PMC8541127, DOI: 10.3390/nu13103516.
- Hayman TJ, Baro M, MacNeil T, Phoomak C, Aung TN, Cui W, Leach K, Iyer R, Challa S, Sandoval-Schaefer T, Burtness BA, Rimm DL, Contessa JN. STING enhances cell death through regulation of reactive oxygen species and DNA damage. Nature Communications 2021, 12: 2327. PMID: 33875663, PMCID: PMC8055995, DOI: 10.1038/s41467-021-22572-8.
- Phoomak C, Cui W, Hayman TJ, Yu SH, Zhao P, Wells L, Steet R, Contessa JN. The translocon-associated protein (TRAP) complex regulates quality control of N-linked glycosylation during ER stress. Science Advances 2021, 7: eabc6364. PMID: 33523898, PMCID: PMC7810369, DOI: 10.1126/sciadv.abc6364.
- Hayman T, Baro M, Cui W, Contessa J. Whole Genome CRISPR-Cas9 Screen Identifies STING as a Determinant of Intrinsic Radiosensitivity in Head and Neck Squamous Cell Carcinoma. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: s77-s78. DOI: 10.1016/j.ijrobp.2019.06.538.
- Hayman T, Hsu A, Kolesnik T, Dagley L, Willemsen J, Tate M, Baker P, Kershaw N, Kedzierski L, Webb A, Wark P, Kedzierska K, Masters S, Belz G, Binder M, Hansbro P, Nicola N, Nicholson S. RIPLET, and not TRIM25, is required for endogenous RIG‐I‐dependent antiviral responses. Immunology And Cell Biology 2019, 97: 840-852. PMID: 31335993, DOI: 10.1111/imcb.12284.
- Chen WS, Bindra RS, Mo A, Hayman T, Husain Z, Contessa JN, Gaffney SG, Townsend JP, Yu JB. CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma. Frontiers In Oncology 2018, 8: 95. PMID: 29670856, PMCID: PMC5893829, DOI: 10.3389/fonc.2018.00095.
- Hayman T, Bledsoe T, Corso C, Lester-Coll N, Park H, Decker R. Increasing Utilization of Stereotactic Radiation Therapy as a Component of Initial Therapy in Metastatic Non–small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e459. DOI: 10.1016/j.ijrobp.2017.06.1702.
- Chen W, Bindra R, Mo A, Hayman T, Husain Z, Contessa J, Yu J. (S032) Investigating CDKN2A Copy Number Loss in HPV- and HPV+ Head and Neck Cancer: A Demonstration of Integrated Genomic and Clinical Analyses Using TCGA. International Journal Of Radiation Oncology • Biology • Physics 2017, 98: e10. DOI: 10.1016/j.ijrobp.2017.02.068.
- Chen W, Bindra R, Mo A, Hayman T, Husain Z, Contessa J, Gaffney S, Townsend J, Yu J. CDKN2A copy number loss in HPV- and HPV+ head and neck cancer to indicate poor prognosis: An integrated genomic and clinical TCGA analysis. Journal Of Clinical Oncology 2017, 35: 6060-6060. DOI: 10.1200/jco.2017.35.15_suppl.6060.
- Hayman T, Contessa J. Receptor Tyrosine Kinases as Targets for Enhancing Tumor Radiosensitivity. Cancer Drug Discovery And Development 2016, 35-55. DOI: 10.1007/978-3-319-40854-5_2.
- Hayman T, Strom T, Springett G, Balducci L, Hoffe S, Meredith K, Hodul P, Malafa M, Shridhar R. Outcomes of resected pancreatic cancer in patients age ≥70. Journal Of Gastrointestinal Oncology 2015, 6: 498-504. PMID: 26487943, PMCID: PMC4570916, DOI: 10.3978/j.issn.2078-6891.2015.038.
- Hayman T, Strom T, Springett G, Balducci L, Hoffe S, Meredith K, Malafa M, Shridhar R. Pancreatic Cancer Outcomes in Resected Age ≥ 70 Patients Are Comparable to Younger Patients. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s361. DOI: 10.1016/j.ijrobp.2014.05.1172.
- Hayman T, Wahba A, Rath B, Bae H, Kramp T, Shankavaram U, Camphausen K, Tofilon P. The ATP-Competitive mTOR Inhibitor INK128 Enhances In Vitro and In Vivo Radiosensitivity of Pancreatic Carcinoma Cells. Clinical Cancer Research 2014, 20: 110-119. PMID: 24198241, PMCID: PMC3947297, DOI: 10.1158/1078-0432.ccr-13-2136.
- Kahn J, Hayman T, Jamal M, Rath B, Kramp T, Camphausen K, Tofilon P. The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells. Neuro-Oncology 2013, 16: 29-37. PMID: 24311635, PMCID: PMC3870843, DOI: 10.1093/neuonc/not139.
- Kahn J, Hayman T, Camphausen K, Tofilon P. The mTORC1/mTORC2 Inhibitor AZD2014 Enhances the Radiosensitivity of Glioblastoma Stem-like Cells. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s697. DOI: 10.1016/j.ijrobp.2012.07.1863.
- Chuong M, Hayman T, Patel M, Russell M, Malafa M, Hodul P, Springett G, Shridhar R, Hoffe S, Choi J. 3D Analysis of Tumor Response to Neoadjuvant Chemotherapy (GTX) and Intensity Modulated Radiation Therapy in Patients with Borderline Resectable Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s301. DOI: 10.1016/j.ijrobp.2010.07.715.
Locations
Yale Therapeutic Radiology
Smilow Cancer Hospital at Yale New Haven
35 Park Street, Fl Ste Lower Level
New Haven, CT 06511
- Yale Therapeutic RadiologySmilow Cancer Hospital at Yale New Haven35 Park Street, Fl Ste Lower LevelNew Haven, CT 06511
Biography
Thomas Hayman, MD, PhD, is a therapeutic radiologist who specializes in treating cancers of the lung, head and neck, skin, and more. He employs advanced radiation techniques, including stereotactic radiosurgery and intensity-modulated radiation therapy (which uses precise computer planning to target tumors), to manage various malignancies such as those in the central nervous system, prostate, and gastrointestinal tract.
As an assistant professor of therapeutic radiology at Yale School of Medicine, Dr. Hayman studies how cancer cells resist damage from radiation. He aims to discover better ways to overcome these defenses, ultimately translating new findings into clinical practice.
Dr. Hayman received his medical degree and doctoral degree from the University of South Florida Morsani College of Medicine. He completed a residency in radiation oncology at Yale New Haven Hospital.
Titles
- Assistant Professor of Therapeutic Radiology
Education & Training
- MDUSF Health Morsani College of Medicine (2015)
- PhDUSF Health Morsani College of Medicine (2013)
Additional Information
Board Certifications
- AB of Radiology, Radiation Oncology (2021)
Publications
- Ninia JG, Verma N, Long JB, Laird JH, Hicks DF, Hayman TJ, Knowlton CA, Campbell AM, Housri N, Peters GW, Al Feghali KA, de Jong D, Chiang AC, Park HS. Consolidative Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Outcomes Based on Completeness of Consolidation and Oligometastatic State. Clinical Lung Cancer 2026, 27 DOI: 10.1016/j.cllc.2026.03.009.
- MacNeil T, Hayman T, Li S, Moutafi M, Martinez-Morilla S, Vathiotis I, Hu R, Harari P, Burtness B, Liu H, Kimple R, Rimm D, Contessa J. STING predicts patterns of failure in locally advanced head and neck squamous cell carcinoma. JNCI Cancer Spectrum 2026, 10: pkaf126. PMID: 41569294, PMCID: PMC12972654, DOI: 10.1093/jncics/pkaf126.
- Ziaks T, Park H, Oh P, Hicks D, Knowlton C, Laird J, Hayman T. P3.13.26 Sequencing of Stereotactic Body Radiation Therapy and Chemotherapy in Stage I Small Cell Lung Cancer: Practice Patterns and Outcomes. Journal Of Thoracic Oncology 2025, 20: s516. DOI: 10.1016/j.jtho.2025.09.962.
- Lee V, Oh P, Jani K, Rybkin A, Kim S, Patel A, Kang J, Park H, Hayman T. P1.07.36 A Three-Gene Signature Predicting Local Recurrence in Stage I-III NSCLC Patients Treated With Radiation Therapy. Journal Of Thoracic Oncology 2025, 20: s151. DOI: 10.1016/j.jtho.2025.09.279.
- Shen J, Oh P, Hayman T, Knowlton C, Hicks D, Laird J, Park H. Cardiac Toxicity Following SBRT for Centrally Located Lung Tumors: Assessing the Impact of Radiation Dose Metrics. International Journal Of Radiation Oncology • Biology • Physics 2025, 123: e212. DOI: 10.1016/j.ijrobp.2025.06.3759.
- Lawlor M, Park H, Knowlton C, Housri N, Hicks D, Laird J, Evans S, Hayman T. Retrospective Study of the Efficacy and Safety of Lung Malignancy Radiation In-Field of Prior Ipsilateral Breast Radiation. International Journal Of Radiation Oncology • Biology • Physics 2025, 123: e179-e180. DOI: 10.1016/j.ijrobp.2025.06.3687.
- Lee V, Rybkin A, Oh P, Izreig S, Park H, Morris L, Hayman T, Young M, Pickering C, Mehra S, Lee N, Kang J. The Role of TP53 in Nodal Metastasis: A Molecular Guide for Neck Management in Oral Cavity Cancer. International Journal Of Radiation Oncology • Biology • Physics 2025, 123: s196. DOI: 10.1016/j.ijrobp.2025.07.1284.
- Lee V, Oh P, Rybkin A, Jani K, Patel A, Hayman T, Kim S, Park H. Genomic Predictors of Brain Metastases in Non-Small Cell Lung Cancer: Implications for Early Detection and Targeted Surveillance. International Journal Of Radiation Oncology • Biology • Physics 2025, 123: e180-e181. DOI: 10.1016/j.ijrobp.2025.06.3689.
- Banik K, Hayman T. Role of PLK4 inhibition in cancer therapy. Cancer And Metastasis Reviews 2025, 44: 55. PMID: 40512236, DOI: 10.1007/s10555-025-10271-5.
- Dominguez-Vigil I, Banik K, Baro M, Contessa J, Hayman T. PLK4 Inhibition as a Strategy to Enhance Non-Small Cell Lung Cancer Radiosensitivity. Molecular Cancer Therapeutics 2025, 24: 1350-1361. PMID: 40296663, PMCID: PMC12353405, DOI: 10.1158/1535-7163.mct-24-0978.
- Ninia J, Verma N, Laird J, Hayman T, Knowlton C, Peters G, Campbell A, Housri N, Feghali K, de Jong D, Park H. Complete vs. Incomplete Consolidative Radiotherapy in Patients with Extensive-Stage Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2024, 120: e51. DOI: 10.1016/j.ijrobp.2024.07.1890.
- Hayman T. Rethinking the use of germline CHEK2 mutation as a marker for PARP inhibitor sensitivity. JNCI Cancer Spectrum 2024, 8: pkae045. PMID: 38950525, PMCID: PMC11216723, DOI: 10.1093/jncics/pkae045.
- Verma N, Laird J, Moore N, Hayman T, Housri N, Peters G, Knowlton C, Jairam V, Campbell A, Park H. Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy. Advances In Radiation Oncology 2024, 9: 101500. PMID: 38699671, PMCID: PMC11063223, DOI: 10.1016/j.adro.2024.101500.
- Sasse A, Oh P, Saeed N, Yang D, Hayman T, Knowlton C, Peters G, Campbell A, Laird J, Housri N, Park H. Dose-volume Predictors of Radiation Pneumonitis Following Thoracic Hypofractionated Radiotherapy. International Journal Of Radiation Oncology • Biology • Physics 2024, 118: e5. DOI: 10.1016/j.ijrobp.2023.10.054.
- Dosimetric Factors Associated with Esophagitis Following Hypofractionated Radiotherapy to the ThoraxSasse, Oh P, Saeed N, Yang D, Peters G, Hayman T, Housri N, Laird J, Campbell A, Knowlton C, Park H. Dosimetric Factors Associated with Esophagitis Following Hypofractionated Radiotherapy to the Thorax. International Journal Of Radiation Oncology • Biology • Physics 2024, 118: e7-e8. DOI: 10.1016/j.ijrobp.2023.10.059.
- Bennett C, Jackson V, Pettikiriarachchi A, Hayman T, Schaeper U, Moir-Meyer G, Fielding K, Ataide R, Clucas D, Baldi A, Garnham A, Li-Wai-Suen C, Loughran S, Baxter E, Green A, Alexander W, Bahlo M, Burbury K, Ng A, Pasricha S. Iron homeostasis governs erythroid phenotype in polycythemia vera. Blood 2023, 141: 3199-3214. PMID: 36928379, PMCID: PMC10646816, DOI: 10.1182/blood.2022016779.
- Hayman T, Hickey P, Amann-Zalcenstein D, Bennett C, Ataide R, Sthity R, Khandaker A, Islam K, Stracke K, Yassi N, Watson R, Long J, Westcott J, Krebs N, King J, Black R, Islam M, McDonald C, Pasricha S. Zinc Supplementation with or without Additional Micronutrients Does Not Affect Peripheral Blood Gene Expression or Serum Cytokine Level in Bangladeshi Children. Nutrients 2021, 13: 3516. PMID: 34684517, PMCID: PMC8541127, DOI: 10.3390/nu13103516.
- Hayman TJ, Baro M, MacNeil T, Phoomak C, Aung TN, Cui W, Leach K, Iyer R, Challa S, Sandoval-Schaefer T, Burtness BA, Rimm DL, Contessa JN. STING enhances cell death through regulation of reactive oxygen species and DNA damage. Nature Communications 2021, 12: 2327. PMID: 33875663, PMCID: PMC8055995, DOI: 10.1038/s41467-021-22572-8.
- Phoomak C, Cui W, Hayman TJ, Yu SH, Zhao P, Wells L, Steet R, Contessa JN. The translocon-associated protein (TRAP) complex regulates quality control of N-linked glycosylation during ER stress. Science Advances 2021, 7: eabc6364. PMID: 33523898, PMCID: PMC7810369, DOI: 10.1126/sciadv.abc6364.
- Hayman T, Baro M, Cui W, Contessa J. Whole Genome CRISPR-Cas9 Screen Identifies STING as a Determinant of Intrinsic Radiosensitivity in Head and Neck Squamous Cell Carcinoma. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: s77-s78. DOI: 10.1016/j.ijrobp.2019.06.538.
- Hayman T, Hsu A, Kolesnik T, Dagley L, Willemsen J, Tate M, Baker P, Kershaw N, Kedzierski L, Webb A, Wark P, Kedzierska K, Masters S, Belz G, Binder M, Hansbro P, Nicola N, Nicholson S. RIPLET, and not TRIM25, is required for endogenous RIG‐I‐dependent antiviral responses. Immunology And Cell Biology 2019, 97: 840-852. PMID: 31335993, DOI: 10.1111/imcb.12284.
- Chen WS, Bindra RS, Mo A, Hayman T, Husain Z, Contessa JN, Gaffney SG, Townsend JP, Yu JB. CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma. Frontiers In Oncology 2018, 8: 95. PMID: 29670856, PMCID: PMC5893829, DOI: 10.3389/fonc.2018.00095.
- Hayman T, Bledsoe T, Corso C, Lester-Coll N, Park H, Decker R. Increasing Utilization of Stereotactic Radiation Therapy as a Component of Initial Therapy in Metastatic Non–small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2017, 99: e459. DOI: 10.1016/j.ijrobp.2017.06.1702.
- Chen W, Bindra R, Mo A, Hayman T, Husain Z, Contessa J, Yu J. (S032) Investigating CDKN2A Copy Number Loss in HPV- and HPV+ Head and Neck Cancer: A Demonstration of Integrated Genomic and Clinical Analyses Using TCGA. International Journal Of Radiation Oncology • Biology • Physics 2017, 98: e10. DOI: 10.1016/j.ijrobp.2017.02.068.
- Chen W, Bindra R, Mo A, Hayman T, Husain Z, Contessa J, Gaffney S, Townsend J, Yu J. CDKN2A copy number loss in HPV- and HPV+ head and neck cancer to indicate poor prognosis: An integrated genomic and clinical TCGA analysis. Journal Of Clinical Oncology 2017, 35: 6060-6060. DOI: 10.1200/jco.2017.35.15_suppl.6060.
- Hayman T, Contessa J. Receptor Tyrosine Kinases as Targets for Enhancing Tumor Radiosensitivity. Cancer Drug Discovery And Development 2016, 35-55. DOI: 10.1007/978-3-319-40854-5_2.
- Hayman T, Strom T, Springett G, Balducci L, Hoffe S, Meredith K, Hodul P, Malafa M, Shridhar R. Outcomes of resected pancreatic cancer in patients age ≥70. Journal Of Gastrointestinal Oncology 2015, 6: 498-504. PMID: 26487943, PMCID: PMC4570916, DOI: 10.3978/j.issn.2078-6891.2015.038.
- Hayman T, Strom T, Springett G, Balducci L, Hoffe S, Meredith K, Malafa M, Shridhar R. Pancreatic Cancer Outcomes in Resected Age ≥ 70 Patients Are Comparable to Younger Patients. International Journal Of Radiation Oncology • Biology • Physics 2014, 90: s361. DOI: 10.1016/j.ijrobp.2014.05.1172.
- Hayman T, Wahba A, Rath B, Bae H, Kramp T, Shankavaram U, Camphausen K, Tofilon P. The ATP-Competitive mTOR Inhibitor INK128 Enhances In Vitro and In Vivo Radiosensitivity of Pancreatic Carcinoma Cells. Clinical Cancer Research 2014, 20: 110-119. PMID: 24198241, PMCID: PMC3947297, DOI: 10.1158/1078-0432.ccr-13-2136.
- Kahn J, Hayman T, Jamal M, Rath B, Kramp T, Camphausen K, Tofilon P. The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells. Neuro-Oncology 2013, 16: 29-37. PMID: 24311635, PMCID: PMC3870843, DOI: 10.1093/neuonc/not139.
- Kahn J, Hayman T, Camphausen K, Tofilon P. The mTORC1/mTORC2 Inhibitor AZD2014 Enhances the Radiosensitivity of Glioblastoma Stem-like Cells. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s697. DOI: 10.1016/j.ijrobp.2012.07.1863.
- Chuong M, Hayman T, Patel M, Russell M, Malafa M, Hodul P, Springett G, Shridhar R, Hoffe S, Choi J. 3D Analysis of Tumor Response to Neoadjuvant Chemotherapy (GTX) and Intensity Modulated Radiation Therapy in Patients with Borderline Resectable Pancreatic Cancer. International Journal Of Radiation Oncology • Biology • Physics 2010, 78: s301. DOI: 10.1016/j.ijrobp.2010.07.715.
Locations
Yale Therapeutic Radiology
Smilow Cancer Hospital at Yale New Haven
35 Park Street, Fl Ste Lower Level
New Haven, CT 06511
- Yale Therapeutic RadiologySmilow Cancer Hospital at Yale New Haven35 Park Street, Fl Ste Lower LevelNew Haven, CT 06511
Yale Therapeutic Radiology
Smilow Cancer Hospital at Yale New Haven
35 Park Street, Fl Ste Lower Level
New Haven, CT 06511
- Yale Therapeutic RadiologySmilow Cancer Hospital at Yale New Haven35 Park Street, Fl Ste Lower LevelNew Haven, CT 06511